Schedule
Wednesday
2019-05-29
Thursday
2019-05-30
Friday
2019-05-31
Saturday
2019-06-01
Wednesday
2019-05-29
08:30
- 10:00
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track)
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital
Sharlea Disney
Clinical Quality Consultant, Peter MacCallum Cancer Centre
Wen Bo Wang, PhD
Senior Vice President, Technical Operations, Fate Therapeutics
08:30
- 10:00
CMC Considerations (including testing) for Pediatric Treatments (Global Regulatory Perspectives)
Yoshiaki Maruyama, PhD
Review Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
08:30
- 10:00
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop)
Paul J. Simmons, PhD
Research & New Product Development, Mesoblast
Igor Slukvin, MD, PhD
Professor, University of Wisconsin-Madison, United States
Robert W. Mays, PhD
VP Regenerative Medicine and Head of Neuroscience Programs, Athersys, USA
08:30
- 10:00
Cord Blood Expansion (Cord Blood Series)
Colleen Delaney, MD
Founder and Chief Scientific Officer, Nohla Therapeutics
08:30
- 10:00
ISCT-FACT Quality Bootcamp Session 1
10:00
- 10:15
Coffee Break
10:15
- 11:45
Cord Blood for Neurological Disorders (Cord Blood Series)
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Professor of Pediatrics, Samsung medical Center, Sungkyunkwan University, School of Medicine
Won Soon Park MD, PhD
Professor of Pediatrics, Samsung medical Center, Sungkyunkwan University, School of Medicine
MinYoung Kim MD, PhD
Professor, CHA University
10:15
- 11:45
Risk assessment for administration of non-conforming products (Global Regulatory Perspectives)
10:15
- 11:45
ISCT-FACT Quality Bootcamp Session 2
10:15
- 11:45
Specialized Cell Processing (Cell Processing Track)
Global Head of Process Development, Cell and Gene Technologies, Lonza Walkersville, Inc.
Behnam Baghbaderani, PhD
Global Head of Process Development, Cell and Gene Technologies, Lonza Walkersville, Inc.
Frances Harding, PhD
Cell Therapies Specialist/Project Lead, Cell Therapies Pty. Ltd
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
10:15
- 11:45
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop)
Oscar K. Lee, MD, MSc, PhD
Chair Professor, National Yang-Ming University, Taiwan
Pawan Kumar Gupta, MBBS, MD, DNB, PhD
Senior Director Medical Services, Stempeutics Research
Professor, Center for stem cell biology and tissue engineering, Sun Yat-sen University
Andy Peng Xiang, PhD
Professor, Center for stem cell biology and tissue engineering, Sun Yat-sen University
Director of both Treatment and Research Center for Infectious Diseases and The Institute of Translational Hepatology, Beijing 302 Hospital
Fusheng Wang, MD, PhD,
Director of both Treatment and Research Center for Infectious Diseases and The Institute of Translational Hepatology, Beijing 302 Hospital
10:15
- 11:45
Stem Cell Crystal Ball – Navigating Contemporary Practice and Imagining the Future
Megan Munsie, PhD
Deputy Director, Centre for Stem Cell Systems, University of Melbourne, Australia
Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research
Ashley Ng, MBBS, FRACP, FRACP Haem
Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research
Rosa McCarty, PhD, GCUT
University of Melbourne
11:45
- 13:00
Lunch
13:00
- 14:30
Product Testing and Characterization by Flow Cytometry (Cell Processing Track)
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
13:00
- 14:30
Cord Blood Cellular Therapy (Cord Blood Series)
Professor, Children's National Medical Center & George Washington University, USA
Catherine Bollard, MD
Professor, Children's National Medical Center & George Washington University, USA
Professor of Medicine, University of Texas MD Anderson Cancer Research Center
Katy Rezvani, MBBS, PhD
Professor of Medicine, University of Texas MD Anderson Cancer Research Center
Yufang Shi, PhD
Director, Institutes for Translational Medicine
13:00
- 14:30
ISCT-FACT Quality Bootcamp Session 3
13:00
- 14:30
MSC Regulatory Landscape in Asia (MSC Workshop)
Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Yoji Sato, PhD
Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
13:00
- 14:30
Chief Scientific Officer Emerging Technologies Showcase
Daniel J. Weiss
Professor of Medicine, University of Vermont College of Medicine
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Professor Stem Cell Biology and Regenerative Medicine, The University of Adelaide
Stan Gronthos, PhD
Professor Stem Cell Biology and Regenerative Medicine, The University of Adelaide
13:00
- 14:30
Clinical Strategies for Treatment of Pediatric Diseases (Global Regulatory Perspectives)
14:30
- 14:45
Coffee Break
14:45
- 16:15
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop)
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Yufang Shi, PhD
Director, Institutes for Translational Medicine
Donald Phinney, PhD
Professor, The Scripps Research Institute, Scripps Florida, USA
14:45
- 16:15
Doing Business in Korea
Sung hyun Choi
Project Leader (PL), Daewoong Co., Ltd
Nam Ho Kim
Researcher, Biosolution co., Ltd.
Donghoon Oh
Chief Scientific Officer, STEMLAB, Inc.
San U. Song
Founder and Chief Scientific Officer, SCM Lifescience Co. Ltd
Jooyoun Lee
President of R&D Center, Xcell Therapeutics
Jong Seong Ahn
Research Center Director, Green Cross Cell corp.
Gunsoo Kim
Chief Executive Officer, Curocell Inc.
14:45
- 16:15
ISCT-FACT Quality Bootcamp Session 4
14:45
- 16:15
Global Regulatory Perspectives (GRP) Session 4
14:45
- 16:15
Final Considerations (Cell Processing Track)
Virginia Litwin, PhD
Vice President, Immunology, Caprion Biosciences Inc., Canada
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital
14:45
- 16:15
Cord Blood Derived MSCs, Exosomes, and Regenerative Medicine (Cord Blood Series)
Elizabeth J. Shpall, MD
Professor of Medicine, MD Anderson Cancer Center
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
Helen E. Heslop, MD
Professor of Medicine and Pediatrics, Baylor College of Medicine
16:30
- 18:30
Corporate Symposium Hosted By Miltenyi Biotec
19:00
- 21:30
ISCT 2019 President’s Welcome Address and Exhibit Open House Reception
19:45
- 20:00
ISCT Product Theatre Opening Address – Hosted by CCRM
Thursday
2019-05-30
Plenary Hall
Room 220
Room 213
Room 219
07:30
- 08:30
Corporate Breakfast Tutorial Hosted by Cell Therapies PTY
07:30
- 08:30
Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee (Hot Topic)
George Muschler, MD
Orthopaedic Surgeon, Cleveland Clinic, United States
Nakamura Norimasa, MD, PhD
Professor, Osaka Health Science University, Japan
Research Director, Inserm Institute for Regenerative Medicine and Biotherapies, France
Danièle Noël, PhD
Research Director, Inserm Institute for Regenerative Medicine and Biotherapies, France
Constance Chu, MD
Professor of Orthopaedic Surgery, Stanford University School of Medicine, USA
07:30
- 08:30
Bioengineering of the GI Tract (Hot Topic)
Associate Professor in Gastroenterology, University of Verona School of Medicine, Italy
Rachele Ciccocioppo, MD
Associate Professor in Gastroenterology, University of Verona School of Medicine, Italy
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Giuseppe Orlando, MD, PhD
Assistant Professor, Wake Forest University Baptist Medical Center, USA
08:45
- 09:00
Opening Remarks, Presentation of 2019 ISCT Career Achievement Award in Cell & Gene Therapy and Announcement of 2019 Cell Therapy Training Course Scholars
09:00
- 10:30
Presidential Plenary: CAR Ts Beyond B Cells
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
Weidong Han, MD, PhD
Professor, Chinese PLA General Hospital, China
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
Franco Locatelli, MD, PhD
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
10:30
- 10:45
Corporate Product Theatre hosted By GE Healthcare
10:30
- 11:00
Coffee Break
10:45
- 11:00
Corporate Product Theatre Hosted By Sartorius Stedim Biotech
11:00
- 12:15
Clinical Cell Supply for Commercial CAR-T Products- How to Integrate Regional Rules and Policies into Global Networks (Regulatory Spotlight)
Simon Harrison, MBBS, PhD
Director of Clinical Aphaeresis, Peter MacCallum Cancer Centre, Australia
11:00
- 12:15
Emerging Standards in Cell & Gene Therapies (Quality & Operations Track)
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Claudia Zylberberg, PhD
CEO & Founder, Akron Biotech, USA
Brian Hawkins, PhD
Chief Technology Officer, Pluristyx, Inc., USA
11:00
- 12:15
Enabling Technologies (Plenary Satellite)
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
11:00
- 12:15
Think Big and Think Early To Prevent Failure at Commercial Scale (Strategies for Commercialization Track)
Simon Ellison, MBA
Service Director, Cell and Gene Therapy, World Courier, United Kingdom
Heidi Hagen, MS, MBA
Co-Founder & Chief Strategy Officer Vineti, Inc, USA
Kilian Kelly, PhD
Vice President, Product Development, Cynata Therapeutics, Australia
Andrew McDonald
Director, Australia & New Zealand, World Courier, Australia
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
11:00
- 12:15
Cord-Blood Derived Therapies for Regenerative Medicine & Transplantation (APP Track)
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA
Juliet Barker, MBBS, FRACP
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA
Ngaire Elwood, PhD
Director, BMDI Cord Blood Bank, Australia
Charles S. Cox, MD
Professor of Pediatric Surgery, University of Texas Medical School, USA
11:00
- 12:15
Immunotherapy Oral Abstract Presentations I (Plenary Satellite)
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
12:15
- 13:45
Lunch
12:30
- 12:45
Corporate Product Theatre Hosted By Australian Red Cross Blood Service
12:30
- 13:30
Corporate Tutorial Hosted by GE Healthcare
13:00
- 13:15
Corporate Product Theatre Hosted By AventaCell Biomedical
13:15
- 13:30
Corporate Product Theatre Hosted By Merck
13:45
- 15:15
Plenary 2 – Tissue Engineering
Oscar K. Lee, MD, MSc, PhD
Chair Professor, National Yang-Ming University, Taiwan
Janet Macpherson, PhD
Product Sales Specialist, Cell & Gene Therapy, GE Healthcare, Australia
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Melissa Little, PhD
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Yoshiki Sawa, MD
Professor, Osaka University, Japan
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
15:15
- 15:45
Coffee Break
15:15
- 15:30
Corporate Product Theatre Hosted By Pall
15:30
- 15:45
Corporate Product Theatre Hosted By Pall
15:45
- 17:00
Comparing Gene Editing Technologies in Patients (Organizing Committee Spotlight)
15:45
- 17:00
Applied Risk Assessment (Quality & Operations Track)
Gerry McKiernan, BSc
Quality Manager, Cell Therapies PTY, Australia
Jean Stanton
Director, CAR-T Apheresis Site Liaisons, Janssen Pharmaceuticals, USA
Jeanette Ripper
Cell Therapy Tissue Operations Expert, Australia
Susan Cheong
Senior Quality and Compliance Specialist, Cell Therapies PTY, Australia
15:45
- 17:00
Organoids for Regenerative Medicine (Plenary Satellite)
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Melissa Little, PhD
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Gay Crooks, MBBS
Professor, University of California Los Angeles, United States
David Elliott, PhD
Team Leader, Murdoch Children's Research Institute
15:45
- 17:00
Regulatory Impact on Global Commercialization of Cell & Gene Therapies (Strategies for Commercialization Track)
Owner, Chief Consultant & Advisor Hybrid Concepts International (HCI), United States
Michael Mendicino, PhD
Owner, Chief Consultant & Advisor Hybrid Concepts International (HCI), United States
Dianne Jackson-Matthews, PhD
Chief Scientific Officer, ERA Consulting, Australia
Antonio Lee, PhD
CEO and Managing Director, MEDIPOST Co, Ltd, Korea
15:45
- 17:00
Novel Therapies for Treating Cancer (APP Track)
Professor, Head, Translational Oncology Laboratory, University of South Australia, United States
Michael Brown, MBBS, PhD
Professor, Head, Translational Oncology Laboratory, University of South Australia, United States
Attending Physician, Fred Hutchinson Cancer Research Center, United States
Cameron Turtle, MBBS, PhD
Attending Physician, Fred Hutchinson Cancer Research Center, United States
Cassian Yee, MD
Professor, MD Anderson Cancer Center, United States
15:45
- 17:00
Immunotherapy Oral Abstract Presentations II (Plenary Satellite)
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
Franco Locatelli, MD, PhD
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
17:15
- 18:45
Corporate Symposium Hosted by Terumo BCT
18:00
- 18:30
Elevator Pitch Abstract Presentations
18:00
- 19:30
Poster Session 1
19:00
- 21:00
ISCT Early Stage Professionals Networking Reception – Hosted By Sartorius Stedim Biotech
19:30
- 21:30
ISCT Industry Networking Event
Friday
2019-05-31
06:30
- 07:30
ISCT 2019 5K Run
07:30
- 08:30
Cytotherapy: A New Era
Donald Phinney, PhD
Professor, The Scripps Research Institute, Scripps Florida, USA
Angela Welch, PhD
Senior Publisher, Oncology & Hematology, Elsevier
07:30
- 08:30
Update on CGT Clinical Trials for Stroke/Acute CNS (Hot Topics)
Charles S. Cox, MD
Professor of Pediatric Surgery, University of Texas Medical School, USA
Robert W. Mays, PhD
VP Regenerative Medicine and Head of Neuroscience Programs, Athersys, USA
John Sinden, PhD
Chief Scientific Officer, ReNeuron, United Kingdom
Damien Bates, MD, PhD, MBA
Chief Medical Officer and Head of Research, SanBio, USA
07:30
- 08:30
ISCT-KSBMT Joint Session – Advances in Cellular Therapy for Hematologic Disorders
Professor, Children's National Medical Center & George Washington University, USA
Catherine Bollard, MD
Professor, Children's National Medical Center & George Washington University, USA
Keon Hee Yoo, MD, PhD
Professor, Samsung Medical Center, Korea
07:30
- 08:30
Capital Without Borders: Raising Money for CGT in the Global Economy (Strategies for Commercialization Track)
Patrick Rivers, MBA
Senior Vice-President, Research, Aquilo Capital, United States
Ting Jia, PhD
Founder and Managing Director, Octagon Advisors, United States
Michael Sistenich, MSc
Partner, Aurenda Partners, Australia
08:45
- 10:15
Plenary 3 – ISCT-JSRM Joint Session: Clinical Applications of hPSCs
Ngaire Elwood, PhD
Director, BMDI Cord Blood Bank, Australia
Yoshiki Sawa, MD
Professor, Osaka University, Japan
Professor Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
Jun Takahashi, MD, PhD
Professor Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
Masayo Takahashi, MD, PhD
Project Leader, Retinal Renegeration Laboratory, RIKEN Center, Japan
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
10:15
- 10:30
Corporate Product Theatre Hosted By Thermo Fisher Scientific
10:15
- 10:45
Coffee Break
10:30
- 10:45
Corporate Product Theatre Hosted By Rooster Bio
10:45
- 12:15
Technologist Workshop (Quality & Operations Track)
Quality Manager Q-Gen Cell Therapeutics, QIMR Berghofer Medical Research Institute, Australia
Rosemarie Bell, B.App.Sc Micro/Biochem MASM
Quality Manager Q-Gen Cell Therapeutics, QIMR Berghofer Medical Research Institute, Australia
Heather Garrity, MHA
Lead Cell Processing Specialist, Dana Farber Cancer Institute, USA
Elise Ross, BSc
Quality Control Analyst, Cell Therapies PTY, Australia
Cell Therapy and Regenerative Medicine Platform Manager, Hudson Institute of Medical Research, Australia
Gordon McPhee, PhD
Cell Therapy and Regenerative Medicine Platform Manager, Hudson Institute of Medical Research, Australia
10:45
- 12:15
Production of iPSCs for Clinical Use (Plenary Satellite)
Professor Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
Jun Takahashi, MD, PhD
Professor Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
Igor Slukvin, MD, PhD
Professor, University of Wisconsin-Madison, United States
Professor & Chair Keio University School of Medicine, Department of Orthopedic Surgery, Japan
Masaya Nakamura, MD, PhD
Professor & Chair Keio University School of Medicine, Department of Orthopedic Surgery, Japan
10:45
- 12:15
Manufacturing Efficiencies for Reduction of COGs (Strategies for Commercialization Track)
Ohad Karnieli, PhD, MBA
Founder and CEO, Atvio Biotech, Israel
Jon Rowley, PhD
Founder and Chief Product Officer, RoosterBio, United States
Eric Isberg, PhD
Director of Life Sciences, Entegris, United States
Jeff Liter, MBA
President and CEO, B-MoGen Biotechnologies, USA
10:45
- 12:15
Ethical Issues Across the Cell and Gene Therapy Development Spectrum: From Basic Research to Clinical Translation – Presented by the ISCT Presidential Task Force
Megan Munsie, PhD
Deputy Director, Centre for Stem Cell Systems, University of Melbourne, Australia
Associate Professor, Sydney Health Ethics, Sydney School of Public Health, Australia
Wendy Lipworth, PhD
Associate Professor, Sydney Health Ethics, Sydney School of Public Health, Australia
Sarah Chan, PhD
Chancellor's Fellow, University of Edinburgh, United Kingdom
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Bruce Levine, PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
10:45
- 12:15
Global Pricing & Reimbursement Strategies (Plenary Satellite)
Dawn Driscoll, PhD, MBA
CEO, Cell Therapies PTY, Australia
Jacqueline Barry, PhD
Chief Clinical Officer, Cell & Gene Therapy Catapult, United Kingdom
Nick Crabb, PhD
Program Director - Scientific Affairs, NICE, United Kingdom
Yoshimi Yoshiro, PhD
Associate Professor, Kyoto University, Japan
Felicity McNeill, PSM
Managing Director, Perspicacité, Australia
12:15
- 13:45
Lunch
12:30
- 12:45
Corporate Product Theatre Hosted By Cynata Therapeutics
12:30
- 13:30
Corporate Tutorial Hosted By MaxCyte
12:45
- 13:00
Corporate Product Theatre Hosted By Alliance for Cell and Gene Therapies
13:00
- 13:15
Corporate Product Theatre Hosted By Sartorius Stedim Biotech
13:15
- 13:30
Corporate Product Theatre Hosted By FUJIFILM
Vanda S. Lopes, PhD
Senior Scientist II, R&D, FUJIFILM Irvine Scientific
13:45
- 15:15
Plenary 4 – Commercial Strategies for Expanding Global CGT Access
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Bruce Levine, PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Silviu Itescu, MBBS, FRACP
Chief Executive Officer and Managing Director, Mesoblast, Australia
Tony Liu
Executive Director, CEO, CFO, Cellular Biomedicine Group, China
15:15
- 15:45
Coffee Break
15:45
- 17:00
How Do You Determine Stability of Cell Based Therapies? (Quality & Operations Track)
Nadim Mahmud, MD, PhD
Professor of Medicine, University of Illinois College of Medicine, USA
Melissa Rist
Research Assistant, QIMR Berghofer Medical Research Institute, Australia
Michael Bellio, PhD
Postdoctoral Fellow, University of Miami, USA
15:45
- 17:00
Regulatory & Quality Considerations for iPSC Banking (Plenary Satellite)
Masayo Takahashi, MD, PhD
Project Leader, Retinal Renegeration Laboratory, RIKEN Center, Japan
Stephen Sullivan, PhD, MBA
International Liaison Officer, GAiT
15:45
- 17:00
Supply Chain Consistency (Strategies for Commercialization Track)
Dolores Baksh, PhD
Innovation Leader, Cell & Gene Therapies, GE Healthcare, United States
Dominic Clarke, PhD
Global Head of Cell Therapy, HemaCare, United States